AKTS - Aktis Oncology, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$33.00
DETAILS
HIGH:
$35.00
LOW:
$31.00
MEDIAN:
$33.00
CONSENSUS:
$33.00
UPSIDE:
50.48%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 100.0% |
| EBIT Margin | -1149.5% |
| EBITDA Margin | -1113.7% |
| Operating Margin | -1149.5% |
| Pretax Margin | -980.9% |
| Cont. Ops Margin | -980.9% |
| Net Margin | -980.9% |
| Bottom Line Margin | -980.9% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 7.37 |
| Quick Ratio | 7.37 |
| Solvency Ratio | -0.149 |
| Cash Ratio | 1.21 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-18.46
Peer avg not available.
|
| PEG Ratio | 3.32 |
| Forward PEG | 3.32 |
| Price/Book | -8.05 |
| Price/Sales | 181.08 |
| Price/FCF | -15.96 |
| Price/Op Cash Flow | -18.35 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0436 |
| Debt/Equity | -0.0790 |
| Debt/Capital | -0.0858 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | -1.81 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.03 |
| Operating Cash Flow Ratio | -2.053 |
| Operating Cash Flow/Sales | -987.0% |
| Free Cash Flow/Operating Cash Flow | 114.9% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -5.55 |
| Capital Expenditure Coverage | -6.69 |
| Dividend + Capital Expenditure Coverage | -6.69 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.12 |
| EPS | -1.213 |
| Debt/Share | 0.2199 |
| Cash/Share | 4.32 |
| Book Value/Share | -2.78 |
| Tangible BV/Share | -2.78 |
| Equity/Share | -2.78 |
| Operating Cash Flow/Share | -1.221 |
| Capital Expenditure/Share | 0.182 |
| FCF/Share | -1.403 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.853 |
| Price/Fair Value | -8.05 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -15.90 |